During a follow-up office visit, a 68-year-old man complains of myalgia and fatigue. Since a recent acute myocardial infarction, the patient has been on high-intensity statin therapy. His other health issues include hypertension and type 2 diabetes. There is mild generalized muscle tenderness on examination. The level of creatine kinase in the blood is 456 U/L. TSH and vitamin D levels are within the normal range. The patient's statin therapy is stopped, and he is started on a medication that inhibits cholesterol absorption at the small intestine's brush border. Which of the following drugs was most likely started in this patient?

Question

Quizplus · Accepted Answer

Eductional Objective: Ezetimibe reduces cholesterol absorption in the intestine. As a result, the amount of dietary cholesterol that reaches the liver is reduced. To compensate, the liver increases the expression of LDL receptors, which draw cholesterol out of the circulation.

During a Follow-Up Office Visit, a 68-Year-Old Man Complains of Myalgia